RSS   Newsletter   Contact   Advertise with us

Coherus adds Mary Szela to board of directors

Staff writer | Redwood City, Ca., USA | September 25, 2014
Mary SzelaSeptember 25, 2014, Redwood City, Ca., USA - Coherus BioSciences, Inc., a late-stage biologics platform company, announced the appointment of Mary Szela, chief executive officer of Melinta Therapeutics, Inc., to its board of directors.
Ms. Szela has a 25-year history of creating growth, generating positive organizational change and inspiring high-performing teams. Ms. Szela joined Melinta Therapeutics as director in January 2013 and was named Chief Executive Officer in April 2013.

Prior to that, she held a series of leadership positions at Abbott Laboratories, including Senior Vice President of Global Strategic Marketing and Senior Vice President of U.S. Pharmaceuticals, and was directly responsible for its U.S. pharmaceutical business, where she directed the development and launch of more than eight new pharmaceutical products and multi-billion dollar sales growth for Abbott’s Humira product.

In Abbott’s Hospital Products division, she was responsible for Abbott’s peri-operative, intensive care and pain management pharmaceutical business and the global One 2 One™ outsourcing business.

Ms. Szela also serves on the board of directors of Suneva Medical, Inc. and Melinta Therapeutics, and earned a Bachelor’s degree in Nursing and a Master of Business Administration from the University of Illinois.